Article
Treatment of alopecia areata: “What is new on the horizon?”
1 May 2011
Abstract excerpt
New drug treatment opportunities based on the results of a genome-wide association study, which implicate T cell and natural killer (NK)-cell activation pathways, are leading to new approaches in future clinical trials of alopecia areata. Special attention is being given to the UL 16-binding protein (ULBP3) gene cluster on chromosome 6q25, as these genes make the NKG2D-activating ligand or signal that can trigger...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
